tiprankstipranks

Ecor1 Capital, Llc Insider Profile

25 Followers
Ecor1 Capital, Llc, Ten Percent Owner at Eiger Biopharmaceuticals, holds 13.44M shares in Zymeworks (Ticker: ZYME), holds 3.85M shares in Voyager Therapeutics (Ticker: VYGR), holds 23.17M shares in Prothena (Ticker: PRTA). Most recently, Ecor1 Capital, Llc Bought ― shares of Zymeworks on Jun 21, 2023 for an estimated value of 27.20M.
tipranks
Ecor1 Capital, Llc

Ecor1 Capital, Llc
Eiger Biopharmaceuticals (EIGR)
Ten Percent Owner

Ranked #34,030 out of 102,989 Corporate Insiders

Profitable Transactions

48%
14 out of 29 Profitable Transactions

Average Return

+1.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2B
77.81%
13.89%
5.39%
2.58%
0.33% Others
A breakdown of Ecor1 Capital, Llc's holdings

Insider Roles

Prothena
(PRTA)
Ten Percent Owner
AnaptysBio
(ANAB)
Ten Percent Owner
Zymeworks
(ZYME)
Ten Percent Owner
Voyager Therapeutics
(VYGR)
Ten Percent Owner
+4 other positions
Roles that Ecor1 Capital, Llc holds in companies

Most Profitable Insider Trade

Stock:
Corvus Pharmaceuticals
(CRVS)
Rating:Informative Sell
Date:Oct 01, 2021 - Oct 01, 2022
Return:+82.90%
The most profitable trade made by Ecor1 Capital, Llc

Ecor1 Capital, Llc's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Eiger Biopharmaceuticals
Jun 30, 2015
Ten Percent Owner
Informative Buy
$2.67M
AKUS
AKOUOS
Jul 02, 2020
Uninformative Buy
$26.26M
Surface Oncology
Sep 03, 2020
Ten Percent Owner
Informative Sell
2.38M
$3.95M
Prothena
May 09, 2022
Ten Percent Owner
Informative Sell
30.84M
$1.63B
AnaptysBio
May 09, 2022
Ten Percent Owner
Informative Buy
14.45M
$290.31M
Corvus Pharmaceuticals
Oct 01, 2021
Ten Percent Owner
Informative Sell
25.04M
$170.26K
Odonate Therapeutics
Dec 10, 2021
Ten Percent Owner
Informative Buy
308.66K
$0.00
Voyager Therapeutics
Jan 11, 2023
Ten Percent Owner
Informative Sell
7.14M
$53.88M
Zymeworks
Jun 21, 2023
Ten Percent Owner
Informative Buy
27.20M
$112.61M
GNVC
GenVec Inc
May 27, 2014
Informative Buy
54.04K
$6.92M
List of latest transactions for each holding click on a transaction to see Ecor1 Capital, Llc's performance on stock

Ecor1 Capital, Llc insider profile FAQ

What is the percentage of profitable transactions made by Ecor1 Capital, Llc?
The percentage of profitable transactions made by Ecor1 Capital, Llc is 48%.
    What is the average return per transaction made by Ecor1 Capital, Llc?
    The average return per transaction made by Ecor1 Capital, Llc is 1.40%.
      What stocks does Ecor1 Capital, Llc hold?
      Ecor1 Capital, Llc holds: EIGR, AKUS, SURF, PRTA, ANAB, CRVS, ODTC, VYGR, ZYME, GNVC stocks.
        What was Ecor1 Capital, Llc’s latest transaction?
        Ecor1 Capital, Llc latest transaction was an Informative Buy of $27.20M.
          What was Ecor1 Capital, Llc's most profitable transaction?
          Ecor1 Capital, Llc’s most profitable transaction was an Informative Sell of CRVS stock on October 1, 2021. The return on the trade was 82.90%.
            What is Ecor1 Capital, Llc's role in Eiger Biopharmaceuticals?
            Ecor1 Capital, Llc's role in Eiger Biopharmaceuticals is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.